
366.51 Delayed Data As of Jan 26 | ![]() Today’s Change | 340.10 Today|||52-Week Range 466.14 | -5.90% Year-to-Date |
J&J (JNJ) Q4 Earnings Beat, Sales Miss, 2023 EPS View Upbeat Jan 24 / Zacks.com - Paid Partner Content | Roche (RHHBY) Tecentriq Meets Adjuvant Liver Cancer Study Goal Jan 19 / Zacks.com - Paid Partner Content |
FDA Rejects Accelerated Nod to Lilly's (LLY) Alzheimer's Drug Jan 20 / Zacks.com - Paid Partner Content | The Zacks Analyst Blog Highlights UnitedHealth Group, The Coca-Cola, Roche Holding, Lam Research and Valero Energy Jan 17 / Zacks.com - Paid Partner Content |
Seagen's (SGEN) Tukysa Gets Accelerated FDA Nod for New Indication Jan 20 / Zacks.com - Paid Partner Content |
Previous close | 369.98 |
Today’s open | 366.51 |
Day’s range | 366.51 - 366.51 |
Volume | 5 |
Average volume (3 months) | 79 |
Market cap | $39.1B |
Earnings growth (last year) | +0.63% |
Earnings growth (this year) | -- |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | +10.55% |
P/E ratio | -- |
Price/Sales | 5.62 |
Price/Book | 10.91 |
No competitors data available. |
Next reporting date | -- |
EPS forecast (this quarter) | -- |
Annual revenue (last year) | $68.7B |
Annual profit (last year) | $15.2B |
Net profit margin | 22.18% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Basel, Basel-stadt (basle Town) |